These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Duchenne muscular dystrophy: issues in expanding newborn screening. Kemper AR; Wake MA Curr Opin Pediatr; 2007 Dec; 19(6):700-4. PubMed ID: 18025940 [TBL] [Abstract][Full Text] [Related]
3. The incidence of Duchenne muscular dystrophy in eastern Austria. The controversy regarding CK screening. Hauser E; Toifl K; Mad A; Bittner R Wien Klin Wochenschr; 1993; 105(15):433-6. PubMed ID: 8104369 [TBL] [Abstract][Full Text] [Related]
10. An urgent need for a change in policy revealed by a study on prenatal testing for Duchenne muscular dystrophy. Helderman-van den Enden AT; Madan K; Breuning MH; van der Hout AH; Bakker E; de Die-Smulders CE; Ginjaar HB Eur J Hum Genet; 2013 Jan; 21(1):21-6. PubMed ID: 22669413 [TBL] [Abstract][Full Text] [Related]
11. Cardiomyopathy of Duchenne muscular dystrophy: current understanding and future directions. Spurney CF Muscle Nerve; 2011 Jul; 44(1):8-19. PubMed ID: 21674516 [TBL] [Abstract][Full Text] [Related]
12. Duchenne muscular dystrophy newborn screening: the first 50,000 newborns screened in Taiwan. Chien YH; Lee NC; Weng WC; Chen LC; Huang YH; Wu CS; Hwu WL Neurol Sci; 2022 Jul; 43(7):4563-4566. PubMed ID: 35562557 [TBL] [Abstract][Full Text] [Related]
14. Muscular Dystrophy Surveillance Tracking and Research Network (MD STARnet): case definition in surveillance for childhood-onset Duchenne/Becker muscular dystrophy. Mathews KD; Cunniff C; Kantamneni JR; Ciafaloni E; Miller T; Matthews D; Cwik V; Druschel C; Miller L; Meaney FJ; Sladky J; Romitti PA J Child Neurol; 2010 Sep; 25(9):1098-102. PubMed ID: 20817884 [TBL] [Abstract][Full Text] [Related]
15. [Early diagnosis of Duchenne muscular dystrophy by means of non selective neonatal screening]. Martín Fernandez-Mayoralas D; San Antonio-Arce V; Campos-Castelló J Rev Neurol; 2002 Sep 16-30; 35(6):595-6. PubMed ID: 12389180 [No Abstract] [Full Text] [Related]
16. Duchenne muscular dystrophy in the Western Cape, South Africa: Where do we come from and where are we going? Esterhuizen AI; Greenberg LJ; Ballo R; Goliath RG; Wilmshurst JM S Afr Med J; 2016 May; 106(6 Suppl 1):S67-71. PubMed ID: 27245531 [TBL] [Abstract][Full Text] [Related]
17. Neonatal screening for treatable and untreatable disorders: prospective parents' opinions. Plass AM; van El CG; Pieters T; Cornel MC Pediatrics; 2010 Jan; 125(1):e99-106. PubMed ID: 20026497 [TBL] [Abstract][Full Text] [Related]
18. Screening for Duchenne muscular dystrophy in Germany, 1977-2011: A personal story. Scheuerbrandt G Muscle Nerve; 2018 Feb; 57(2):185-188. PubMed ID: 28981144 [TBL] [Abstract][Full Text] [Related]
19. Delayed diagnosis in duchenne muscular dystrophy: data from the Muscular Dystrophy Surveillance, Tracking, and Research Network (MD STARnet). Ciafaloni E; Fox DJ; Pandya S; Westfield CP; Puzhankara S; Romitti PA; Mathews KD; Miller TM; Matthews DJ; Miller LA; Cunniff C; Druschel CM; Moxley RT J Pediatr; 2009 Sep; 155(3):380-5. PubMed ID: 19394035 [TBL] [Abstract][Full Text] [Related]
20. Three years' experience with neonatal screening for Duchenne/Becker muscular dystrophy: gene analysis, gene expression, and phenotype prediction. Greenberg CR; Jacobs HK; Halliday W; Wrogemann K Am J Med Genet; 1991 Apr; 39(1):68-75. PubMed ID: 1867267 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]